Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies

Leukemia and Lymphoma

Volumn 33, Issue 3-4, 1999, Pages 207-218

  Thiele, Juergen ^a   Kvasnicka, Hans Michael ^a   Diehl, Volker ^a   Fischer, Robert ^a   Michiels, Jan Jacques ^b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Goodheart Institute   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow histology; Chronic myeloproliferative disorders; Clinical findings; Essential (primary) thrombocythemia; Immunohistochemistry; Survival; Thrombocythemia

Indexed keywords

ALKALINE PHOSPHATASE; RETICULIN;

ADULT; ARTICLE; BLEEDING; BONE MARROW BIOPSY; CELL STRUCTURE; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; GRANULOPOIESIS; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLEEN SIZE; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS;

EID: 0032942254     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058421     Document Type: Article

References (50)

1. Michiels, J.J. (1996). The myeloproliferative disorders. A historical appraisal and personal experiences. Leukemia Lymphoma, 22, Suppl 1,1-14.
2. Ravandi-Kashani, F. and Schafer, A.I. (1997). Microvascular disturbances, thrombosis and bleeding in thrombocythemia. Semin. Thromb. Hemostas., 23, 479-86.
3. Wehmeier, A., Daum, I., Jamin, H. and Schneider, W. (1991). Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann. Hematol., 63, 101-6.
4. Michiels, J.J., van Genderen, P.J.J., Lindemans, J. and van Vliet HHDM. (1996). Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. Leukemia Lymphoma, 22, Suppl.1, 47-56.
5. Finazzi, G., Budde, U, and Michiels J.J. (1996). Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes. Leukemia Lymphoma, 22, Suppl. 1, 71-8.
6. Mason, J.E., DeVita, V.T., Canellos, G.P. (1974). Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. Blood, 44, 483-487.
7. Burkhardt, R. Bone marrow in megakaryocytic disorders. (1988). Hematol. Oncol. Clin. N. Am., 2, 695-733.
8. Thiele, J., Schneider, G., Hoeppner, B., Wienhold, S., Zankovich, R. and Fischer, R. (1988). Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - features of significance for the diagnosis of primary (essential) thrombocythemia. Virchows Arch. A. Pathol. Anat., 413, 407-17.
9. Buss, D.H., O'Conner, M.L., Woodruff, R.D., Richards, II F. and Brockschmidt, J.K. (1991). Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. Arch. Pathol. Lab. Med., 115, 475-80.
10. Buhr, T., Georgii, A., Schuppan, O., Amor, A. and Kloutsi, V. (1992). Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann. Hematol., 64, 286-91.
11. Burkhardt, R., Bartl, R., Jaeger, K., Frisch, B., Kettner, G., Mahl, G., et al. (1984). Chronic myeloproliferative disorders (CMPD). Path. Res. Pract., 179, 131-86.
12. Georgii, A., Vykoupil, K.F., Buhr, T., Choritz, H., Döhler, U., Kaloutsi, V., et al. (1990). Chronic myeloproliferative disorders in bone marrow biopsies. Path. Res. Pract., 186, 3-27.
13. Dickstein, J.I. and Vardiman, J.W. (1993). Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol. 99, 513-25.
14. Bartl, R., Frisch, B. and Wilmanns, W. (1993). Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol., 50, 41-52.
15. Iland, H.J., Laszlo, J., Peterson, P., Murphy, S., Brière, J., Weinfeld, A., et al. (1983). Essential thrombocythemia: clinical and laboratory characteristics at presentation. Trans. Assoc. Am. Phys., 96, 165-74.
16. Murphy, S., Iland, H., Rosenthal, D. and Laszlo, J. (1986). Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin, Hematol., 23, 177-82.
17. Iland, H.J., Laszlo, J., Case, D.C., Murphy, S., Reichert, T.A., Tso, C.Y., et al. (1987). Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis. Am. J. Hematol., 25, 191-201.
18. Thiele, J., Kvasnicka, H.M., Werden, C., Zankovich, R., Diehl, V. and Fischer, R. (1996). Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leukemia Lymphoma, 22, 303-17.
19. Gatter, K.C., Cordell, J.L., Turley, H., Heryet, A., Kiefer, N., Anstee, D.J., et al. (1988). The immunohistological detection of platelet, megakaryocytes and thrombi in routinely processed specimens. Histopathology, 13, 257-67.
20. Mahmood, T., Robinson, W.A., Hamstra, R.D. and Wallner, S.F. (1979). Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes. The 5q-syndrome, a distinct entity. Am. J. Med., 66, 946-955.
21. Michiels, J.J. (1997). Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia. Neth. J. Med., 51, 57-64.
22. Michiels, J.J. and Juvonen E. (1997). Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin. Thromb. Hemostas., 23, 339-47.
23. Mathew, P., Terrefi, A., Dewald, G.W., Soldberg, S.L., Su, J., Hoagland, H.C., et al. (1993). The 5q-syndrome: a single-institution study of 43 consecutive patients. Blood, 81, 1040-5.
24. Thiele, J., Kvasnicka, H.M., Titius, B.R., Parpert, U., Nebel, R., Zankovich, R., et al. (1993). Histological features of prognostic significance in CML - an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann. Hematol., 66, 261-302.
25. Kaplan, E.L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-81.
26. Hakama, M. and Hakulinen, T. (1977). Estimating the expectation of life in cancer survival studies with incomplete follow-up informations. J. Chron. Dis., 30, 585-97.
27. Hakulinen, T. (1982). Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics, 32, 933-42.
28. Thiele, J. and Fischer, R. (1991). Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Archiv A. Pathol. Anat., 418, 87-97.
29. Bellucci, S., Janvier, M., Tobelem, G., Flandrin, G., Charpak, Y., Berger, R., et al. (1986). Essential thrombocythemias. Clinical evolutionary and biological data. Cancer, 58, 2440-7.
30. Hehlmann, R., Jahn, M., Baumann, B. and Köpcke, W. (1988). Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer, 61, 2487-96.
31. Fenaux, P., Simon, M., Caulier, M.T., Lai, J.L., Goudemmand, J. and Bauters, F.(1990). Clinical course of essential thrombocythemia in 147 cases. Cancer, 66, 549-56.
32. Kutti, J. and Wadenvik, H. (1996). Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leukemia Lymphoma, 22, 41-5.
33. Thiele, J., Zankovich, R., Steinberg, T., Kremer, B., Fischer, R. and Diehl., V. (1989). Primary (essential) thrombocythemia versus initial (hyperplastic)stages of agnogenic myeloid metaplasia with thrombocytosis - A critical evaluation of clinical and histomorphological data. Acta Haemat., 81, 192-202.
34. Dickstein, J.I. and Vardiman, J.W. (1995). Hematopathologic findings in the myeloproliferative disorders. Semin. Oncol., 22,355-73.
35. Bilgrami, S. and Greenberg, B.R. (1995). Polycythemia rubra vera. Semin. Oncol., 22, 307-26.
36. Ellis, J.T., Peterson, P., Geller, S.A. and Rappaport, H. (1986). Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin. Hematol., 23, 144-55.
37. Lemoine, F., Najman, A., Baillou, C., Stachowiak, J., Boffa, G., Aegerter, P., et al. (1986). A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood, 68, 996-1002.
38. Thiele, J., Zankovich, R., Schneider, G., Kremer, B., Fischer, R. and Diehl., V. (1988). Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies. Analyt. Quant. Cytol. Histol., 10, 375-82.
39. 9/1 be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br. J. Haematol., 100, 5-23.
40. Kaloutsi, V., Fritsch, R.S., Buhr, R., Restrepo-Specht, I, Widjaja, W, and Georgii, A. (1991). Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities. Virchows Arch. A. Pathol. Anat., 418, 493-7.
41. Nafe, R., Georgii, A., Kaloutsi, V., Fritsch, R.S. and Choritz, H. (1991). Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Archiv B Cell. Pathol., 61, 111-6.
42. Buhr, T., Georgii, A. and Choritz, H. (1993). Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Path. Res. Pract., 189, 121-132.
43. Thiele, J., Chen, Y.S., Kvasnicka, H.M., Diehl, V. and Fischer, R.(1994). Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis - a histomorphometric study on sequential trephine biopsies. Leukemia Lymphoma, 14, 163-169.
44. Georgii, A., Buhr, T., Buesche, G., Kreft, A., Choritz, H.(1996). Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leukemia Lymphoma, 22 Suppl. 1, 15-29.
45. Wolf, B.C. and Neiman, R.S. (1985). Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood, 65, 803-9.
46. Rozman, C., Giralt, M., Feliu, R., Rubio, D. and Cortes, M.T. (1991). Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer, 67, 2658-63.
47. Anger, B., Seidler, R., Haug, U., Popp, C. and Heimpel, H. (1990). Idiopathic myelofibrosis: a retrospective study of 103 patients. Haematologica, 75, 228-34.
48. Visani, G., Finelli, C., Castelli., U, Petti, M.C., Ricci, R., Vianelli, N., et al. (1990). Myelofibrosis with myeloid metaplasia, clinical and haematological parameters predicting survival in a series of 133 patients. Br. J. Haematol., 75, 4-9.
49. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantrier, I., et al. (1996). Prognostic factors on agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-18.
50. Kvasnicka, H.M., Thiele, J., Werden, C., Zankovich, R., Diehl, V. and Fischer, R. (1997). Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer, 80, 708-19.